Atractylenolide I Induces Apoptosis and Suppresses Glycolysis by Blocking the JAK2/STAT3 Signaling Pathway in Colorectal Cancer Cells
Colorectal cancer (CRC) is the third most common cancer worldwide and is associated with a poor clinical outcome and survival. Therefore, the development of novel therapeutic agents for CRC is imperative. Atractylenolide I (AT-I) is a sesquiterpenoid lactone derivative of Rhizoma Atractylodis macroc...
Main Authors: | Yanxi Li, Yongpeng Wang, Zhexian Liu, Xingqi Guo, Ziwei Miao, Siping Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00273/full |
Similar Items
-
The Anticancer Effects of Atractylenolide III Associate With the Downregulation of Jak3/Stat3-Dependent IDO Expression
by: Jun-bao Liu, et al.
Published: (2020-01-01) -
Activation of ERK and Mutual Regulation of Stat3 and SP1 Contribute to Inhibition of PDK1 Expression by Atractylenolide-1 in Human Lung Cancer Cells
by: Qian Xiao, et al.
Published: (2017-10-01) -
Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways
by: Jing Wang, et al.
Published: (2018-12-01) -
Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway
by: Cui C, et al.
Published: (2019-07-01) -
Atractylenolide II Inhibits Proliferation, Motility and Induces Apoptosis in Human Gastric Carcinoma Cell Lines HGC-27 and AGS
by: Shuang Tian, et al.
Published: (2017-11-01)